+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Next Generation Sequencing Market by Technology, Product, End-users, and Geography - Global Forecast and Analysis 2019-2023 - Product Image

Next Generation Sequencing Market by Technology, Product, End-users, and Geography - Global Forecast and Analysis 2019-2023

  • ID: 4833943
  • Report
  • September 2019
  • Region: Global
  • 152 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Merck KGaA
  • MORE
Global Next Generation Sequencing Market: About this market

The next generation sequencing market analysis considers sales from both consumables and equipment products. Our analysis also considers the sales of next generation sequencing in Asia, Europe, North America, and ROW. In 2018, the consumables segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as technological advances, and repetitive purchase of a broad range of NGS consumables such as test kits, assays, buffers, and reagents will play a significant role in the consumables segment to maintain its market position. Also, our global next generation sequencing market report looks at factors such as increased utilization of NGS methods, G rowing demand for early diagnosis of genetic disorders, availability of wide range of NGS products. However, lack of clinical validation on direct-to-consumer genetic tests, limited reimbursement policies, and challenges in implementing NGS workflow may hamper the growth of the next generation sequencing industry over the forecast period.

Global Next Generation Sequencing Market: Overview

Growing demand for early diagnosis of genetic disorders

The need to prevent physical disabilities and health conditions in newborns is increasing the demand for early diagnosis among expecting parents. Pre-implantation diagnostic tests facilitates the determination of genetic disorders, such as cystic fibrosis, congenital hearing loss, and thalassemia. Thus, parents are increasingly opting for preimplantation testing, which increases the adoption of NGS techniques. Sequencing technology allows for a simple PGS workflow with flexible sample throughput for consistent and quick aneuploidy detection. Thus, the growing demand for early diagnosis of genetic disorders will drive the growth of the next generation sequencing market at a CAGR of over 19% during the forecast period.

Reduced costs of gene sequencing

Advances in high-throughput genetic testing procedures, biochip, and new generation sequencing (NGS) techniques have reduced the costs of gene sequencing significantly. This has led the vendors to offer low-cost services and overcome cost-related challenges . The adoption of next generation sequencing and fluorescence-based dully automated sequencing technologies have also reduced the cost of sequencing and improved the accuracy in gene sequencing. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of several major players, the global next generation sequencing market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing manufacturers, that include Bio-Rad Laboratories Inc., Eurofins GSC Lux Sarl, F. Hoffmann-La Roche Ltd., Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN Group, Thermo Fisher Scientific Inc.

Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Merck KGaA
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TECHNOLOGY
  • Market segmentation by technology
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2018-2023
  • Equipment - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Advances in NGS techniques
  • Reduced costs of gene sequencing
  • Developments in the field of bioinformatics and cloud-based software programs
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Thermo Fisher Scientific Inc.
PART 16: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Vendor offering overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 22: Equipment - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Equipment - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by end-user 2018 (%)
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 46: Bio-Rad Laboratories Inc. - Business segments
Exhibit 47: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 48: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 49: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 50: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 51: Eurofins GSC Lux Sarl - Vendor overview
Exhibit 52: Eurofins GSC Lux Sarl - Business segments
Exhibit 53: Eurofins GSC Lux Sarl - Organizational developments
Exhibit 54: Eurofins GSC Lux Sarl - Geographic focus
Exhibit 55: Eurofins GSC Lux Sarl - Segment focus
Exhibit 56: Eurofins GSC Lux Sarl - Key offerings
Exhibit 57: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 58: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 59: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 60: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 61: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 62: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 63: Illumina Inc. - Vendor overview
Exhibit 64: Illumina Inc. - Business segments
Exhibit 65: Illumina Inc. - Organizational developments
Exhibit 66: Illumina Inc. - Geographic focus
Exhibit 67: Illumina Inc. - Segment focus
Exhibit 68: Illumina Inc. - Key offerings
Exhibit 69: Invitae Corp. - Vendor overview
Exhibit 70: Invitae Corp. - Business segments
Exhibit 71: Invitae Corp. - Organizational developments
Exhibit 72: Invitae Corp. - Geographic focus
Exhibit 73: Invitae Corp. - Key offerings
Exhibit 74: Laboratory Corp. of America Holdings - Vendor overview
Exhibit 75: Laboratory Corp. of America Holdings - Business segments
Exhibit 76: Laboratory Corp. of America Holdings - Organizational developments
Exhibit 77: Laboratory Corp. of America Holdings - Geographic focus
Exhibit 78: Laboratory Corp. of America Holdings - Segment focus
Exhibit 79: Laboratory Corp. of America Holdings - Key offerings
Exhibit 80: Merck KGaA - Vendor overview
Exhibit 81: Merck KGaA - Business segments
Exhibit 82: Merck KGaA - Organizational developments
Exhibit 83: Merck KGaA - Geographic focus
Exhibit 84: Merck KGaA - Segment focus
Exhibit 85: Merck KGaA - Key offerings
Exhibit 86: PerkinElmer Inc. - Vendor overview
Exhibit 87: PerkinElmer Inc. - Business segments
Exhibit 88: PerkinElmer Inc. - Organizational developments
Exhibit 89: PerkinElmer Inc. - Geographic focus
Exhibit 90: PerkinElmer Inc. - Segment focus
Exhibit 91: PerkinElmer Inc. - Key offerings
Exhibit 92: QIAGEN Group - Vendor overview
Exhibit 93: QIAGEN Group - Product segments
Exhibit 94: QIAGEN Group - Organizational developments
Exhibit 95: QIAGEN Group - Geographic focus
Exhibit 96: QIAGEN Group - Segment focus
Exhibit 97: QIAGEN Group - Key offerings
Exhibit 98: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 99: Thermo Fisher Scientific Inc. - Business segments
Exhibit 100: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 101: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 102: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 103: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 104: Validation techniques employed for market sizing
Exhibit 105: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Merck KGaA
  • MORE
The following companies are recognised as the key players in the global next generation sequencing market: Bio-Rad Laboratories Inc., Eurofins GSC Lux Sarl, F. Hoffmann-La Roche Ltd., Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN Group, Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the reduced costs of gene sequencing.”

According to the report, one of the major drivers for this market is the growing demand for early diagnosis of genetic disorders.

Further, the report states that one of the major factors hindering the growth of this market is the challenges in implementing NGS workflow.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bio-Rad Laboratories Inc.
  • Eurofins GSC Lux Sarl
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll